Wang Tingliang

New Capabilities

As of September 2026: Active

Westlake University announced September 2 that China's drug regulator conditionally approved Mprosevir, a COVID-19 treatment. It is the country's first 'Class 1' innovative drug developed with AI assistance—the highest tier of China's drug registration system, for drugs never marketed before.

Updated Sep 7